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1. Introduction 
Mocimycin [ 1,2] , an antibiotic identical to 
kirromycin [3], is known to block protein synthesis 
in an E. coli cell-free system [4], by preventing the 
release of the elongation factor Tu (EF-Tu) from the 
ribosome during the elongation cycle [S-8]_ 
In this paper we describe the isolation of a moci- 
mycin resistant mutant of E. coli. The resistant 
character of the mutant is caused by an alteration in 
the target protein, EF-Tu. Genetically this resistance 
appears to reside in at least two genes at 72’ and 88’ 
of the new E. coli linkage map [9]. 
2. Materials and methods 
2.1. Materials 
Cell-free extracts, [14C]phenylanyl-tRNA and 
EF-Tu were prepared as described by Lupker et al. 
[lo]. Ribosomes from E. coli MRE 600 were 
prepared as described by Voorma et al. [ 1 l] and 
washed once with 1 M NH4C1. They depend 
completely on the addition of EF-Tu for poly(U)- 
directed polyphenylalanine synthesis. 
Mocimycin was provided by Dr R. Beukers (Gist- 
Brocades NV, Research and Development, Delft, The 
Netherlands). 
Ethylmethane Sulfonate (EMS) was purchased 
from Eastman Kodak Co., the culture media were 
from Difco Laboratories, the radiochemicals from the 
Radiochemical Centre, Amersham. Bacterial strains 
used are listed in table 1. 
Table 1 
Escherichia coli K12 strains useda 
Strain 
KMBL 1001 
Relevant markers 
F-w- 
Origin 
W 1485 
LBE 2012 mocimycin resistant KMBL 1001 
this paper 
LBE 1310 rpsL(= strA) KMBL 1001 
LBE 1431 metA KMBL 1001 
a All strains are from the stock of the Laboratory of 
Molecular Genetics, State University, Leiden, The 
Netherlands 
Bacteriophage Pl was used in the transduction 
experiments. LC-Medium contains per liter: tryptone, 
10 g; yeast extract, 5 g; NaCl, 8g. M9 medium [12] , 
was supplemented-as indicated in the text. 
2.2. Mutagenesis and selection 
A culture of E. coli, KMBL 1001 was mutagenized 
with EMS according to Miller [ 121. The mutagenized 
culture was diluted ten-fold in M9 medium, supple- 
mented with casamino acids and glucose to a final 
concentration of 0.5% and 0.2% respectively, and 
incubated overnight at 37°C. From this overnight 
culture 0.2 ml was used to inoculate 20 ml of a fresh 
culture which was incubated at 37°C to reach a cell 
density of 3.10’ cells/ml. From this suspension 0.05 ml 
was spread on a LC medium agar plate, containing 
100 pg/ml of mocimycin. This plate was screened for 
visible colonies after 18 h incubation at 37°C. 
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2.3. [ “C’Amino acid incorporation in vivo 
Cells were grown in LC medium at 37°C to a cell 
density of 3.1 O8 cells/ml. They were washed once 
with 0.12 M Tris-HCl, pH 8.0 and resuspended in 
this buffer at a concentration of 3.10’ cells/ml. From 
this suspension 1.8 ml was added to 0.2 ml 0.02 M 
EDTA and incubated for 4 min at 37°C [I 31. 
Samples of 10 ~1 were then diluted ten-fold in M9 
medium containing casamino acids (O.Ol%), glucose 
(0.2%), [‘4C]amino acid mixture (0.5 &i/ml; 
54 mCi/matom C) and mocimycin (dissolved in 
ethanol) as indicated. 
The samples were incubated for 15 min at 37°C 
and assayed for incorporation of the 14C-label into 
hot TCA precipitable material. 
2.4. Polyphenylalanine synthesis in vitro 
Polyphenylalanine synthesis in vitro was tested 
according to Lupker et al. [lo] except that the TCA 
precipitate was heated for 15 min at 95°C instead of 
digested with alkali. 
3. Results 
3.1. Isolation and biochemical characterization of 
the mutant 
Mocimycin resistant colonies were isolated (see 
Methods) and purified on plates containing moci- 
mycin. Suspension cultures were grown of each of 
the purified strains and assayed for [14C]amino acid 
incorporation in vivo. 
In order to exclude in this test the possibility 
that the results are influenced by membrane mutations, 
cells were pretreated with EDTA as described by 
Leive [13] with some minor modifications. 
One of the mutant strains (designated LBE 2012) 
thus showing a decreased sensitivity to mocimycin was 
chosen for further analysis. Figure 1 illustrates that 
the antibiotic concentration required to cause a 50% 
inhibition of amino acid incorporation is about 60 
times higher in the mutant, than it is in the parental 
strain. 
That reduced cell-wall permeability is not respon- 
sible for the decreased in vivo effect of mocimycin is 
corroborated by the effect of the antibiotic on 
in vitro polypeptide synthesis. 
304 
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Fig. 1. [Y] Amino acid incorporation into hot TCA- 
precipitable material as a function of the mocimycin con- 
centration, in cells made permeable by EDTA treatment 
(see Methods). 
In experiments not illustrated here, M&-RNA and 
poly(U)-directed polypeptide synthesis was examined 
in S30 extracts and in cell-free systems consisting of 
a SlOO fraction from either mutant or wild type cells 
supplemented with ribosomes from E. coli MRE 600. 
Here again a very similar response towards the anti- 
biotic was recorded. 
The next step was the deomstration that the 
lowered inhibition of protein synthesis by mocimycin 
is to be ascribed to an alteration of the target protein 
of the antibiotic, EF-Tu. 
Isolation, purification and crystallization of this 
protein follows the same pattern starting from either 
wild type or mutant cells. Both immunologically and 
electrophoretically (on SDS-polyacrylamide gels) 
mutant and wild type EF-Tu behave identically. 
Figure 2 shows the difference in mocimycin sen- 
sitivity between the two protein factors when studied 
in a poly(U)-directed polyphenylalanine synthesizing 
system. The difference amounts to a factor of about 
70 when the antibiotic concentrations causing 50% 
inhibition are compared. Since mocimycin interferes 
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Fig.2. In vitro [r4C]polyphenylalanine synthesis as a 
function of the mocimycin concentration. Reaction 
mixtures of 100 ~1 contain: pure EF-Tu, mutant or wild 
type, 50 pmol; 1 M NH,0washed ribosomes, 20 pmol; 
poly(U), 0.2 pg; [‘4C]phe-tRNA, 27 pmol; GTP, 0.12 mM; 
phosphoenolpyruvate, 5 mM; pyruvate kinase, 1 Mg; Tris- 
HCl, pH 7.8, 50 mM; magnesium acetate, 8 mM; ammonium 
chloride 80 mM, mocimycin (dissolved in 5 ~1 ethanol) as 
indicated. After 10 min at 37°C the samples were assayed 
for incorporation of radioactivity into hot TCA-precipitable 
material. 
with the elongation cycle by causing a retention of 
EF-Tu on the ribosome [8], a block of protein 
synthesis may be expected in the presence of the 
antibiotic when sensitive EF-Tu is added to a system 
containing resistant EF-Tu. 
This expectation is borne out by the following 
experiment: 
Polyphenylalanine synthesis was studied at a 
mocimycin concentration of 2.5 pg/ml, sufficient 
to block the wild type system completely, but 
permitting at least 80% polypeptide synthesis in the 
mutant system (cf. fig.2). Increasing amounts of 
sensitive EF-Tu were added to the system containing 
a fixed amount (50 pmol) of mutant EF-Tu. 
J 
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- 10 30 so- 50 -50 wild type 
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Fig.3. Dominance of mocimycin sensitivity over resistance. 
P~ly-[‘~c] phenylalanine synthesis was examined as is 
indicated in the legend to fig.2, except that the mocimycin 
concentration was kept constant (2.5 pg/ml), whereas the 
EF-Tu concentration varied. In the left-hand panel 50 pmol 
of mutant EF-Tu was supplemented with increasing amounts 
of wild type EF-Tu. In the right-hand panel the wild type 
EF-Tu was present in a constant concentration and the 
mutant EF-Tu varied as is indicated. 
In a complementary experiment the wild type 
EF-Tu concentration was fixed and that of the 
mutant EF-TU varied. 
The results of both series of experiments are 
combined in one curve (fig.3). They show clearly 
that mocimycin sensitivity dominates mocimycin 
resistance as was to be expected considering the mode 
of action of the antibiotic. 
3.2. Genetic characterization 
Jaskunas et al. [14] reported that two genes code 
for EF-Tu, one (fufA) at 72’ the other (fujB) at 88’. 
Cotransduction of mocimycin resistance with 
auxotrophic markers, located close to either tufA or 
tifi was attempted without success. Direct selection 
of mocimycin resistance after Pl transduction from 
the mutant to a number of sensitive strains, including 
the parental strain, was equally unsuccessful. 
This implies that resistance is caused by an altera- 
tion in at least two genes. To establish the position 
of these two genes the mutant was made sensitive 
again by PI -transductions from sensitive strains. In 
one case the donor strain (LBE 1310) was steptomycin 
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Table 2 
Frequency of cotransduction 
September 1977 
EF-Tu gene Selected marker Positiona Frequency of CO-~ 
transduction 
tufA 
tu.fB 
rpsL (= sirA) 
metA 
72’ 0.89 
89’ 0.36 
a Position on the recalibrated linkage map of E. coli K12 [9] 
b Number of colonies tested is 200 in both cases - for details see text 
resistant, and 178 out of 200 streptomycin resistant 
transductants examined appeared to be mocimycin 
sensitive. 
In the other case the metA marker was introduced 
in the mutant via Pl transduction, using LBE 1431 
as a donor. 
Transductants were isolated after two rounds of 
penicillin treatment. One of the metA transductants, 
that had become mocimycin sensitive, was used as a 
recipient in the next PI transduction in which LBE 
2012 acted as the donor. Seventy two out of 200 
colonies, selected on medium lacking methionine, 
appeared to be mocimycin resistant again (table 2). 
4. Discussion 
Theoretically a number of mechanisms may be 
envisioned that causes mocimycin resistance. Besides 
mutations affecting the permeability of the cell 
membrane for the antibiotic or the detoxification of 
the compound, two types of mutations are of great 
interest since they may shed new light on the 
mechanism of protein synthesis. The first is a mutation 
which has altered the target protein EF-Tu to such an 
extent, that the interaction with the antibiotic is 
impaired. The second type is characterized by altera- 
tions in reaction partners of the target protein, e.g., 
ribosomal proteins, such that the action of the anti- 
biotic is counteracted. The experiments reported in 
this paper show, that in this case, EF-Tu itself is 
affected. The discovery by Jaskunas et al. [ 141 of 
two genes coding for EF-Tu raises the question 
whether one or both genes are mutated. Since our 
in vitro experiments with pure EF-Tu show that 
mocimycin sensitivity dominates resistance, a double 
mutation affecting both genes is to be expected. 
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This has been confirmed by our genetic experiments. 
They still leave open the question, however, whether 
both genes are coding for an active resistant EF-Tu or 
that possibly one gene is completely silenced. The 
data presented here confirm the occurrence in the 
intact E. cd chromosome of two genes coding for 
EF-Tu as was previously established by Jaskunas et al. 
[14] on the basis of transcription studies with 
transducing phages. 
It is to be expected that the mutant described 
above will be of considerable value in answering 
questions concerning the functioning and the regula- 
tion of expression of the two EF-Tu genes, the 
distributions of the two gene products in the bacterial 
cell [ 17-191 , the role of EF-Tu in QP-RNA replica- 
tion [20-221 and other biosynthetic processes [23]. 
Recently we learned that Drs E. Fisher and 
A. Parmeggiani have isolated a kirromycin mutant 
of E. coli, which genetically and biochemically 
resembles our mutant. 
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